These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
273 related items for PubMed ID: 2680140
21. Potential of Mw as a prophylactic vaccine against pulmonary tuberculosis. Katoch K, Singh P, Adhikari T, Benara SK, Singh HB, Chauhan DS, Sharma VD, Lavania M, Sachan AS, Katoch VM. Vaccine; 2008 Feb 26; 26(9):1228-34. PubMed ID: 18243430 [Abstract] [Full Text] [Related]
23. [The protective efficacy of BCG against leprosy in São Paulo, Brazil]. Lombardi C, Pedrazzani ES, Pedrazzani JC, Ferreira Filho P, Zicker F. Bol Oficina Sanit Panam; 1995 Nov 26; 119(5):415-21. PubMed ID: 8540997 [Abstract] [Full Text] [Related]
24. The Karimui trial of BCG. 2. Tuberculin reactions in a leprosy-endemic but tuberculosis-free population. Scott GC, Wigley SG, Russell DA. Int J Lepr Other Mycobact Dis; 1966 Nov 26; 34(2):139-46. PubMed ID: 5330190 [No Abstract] [Full Text] [Related]
26. Protective effect of BCG against leprosy and its subtypes: a case-control study in southern Vietnam. Thuc NV, Abel L, Lap VD, Oberti J, Lagrange PH. Int J Lepr Other Mycobact Dis; 1994 Dec 26; 62(4):532-8. PubMed ID: 7868950 [Abstract] [Full Text] [Related]
27. Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity. Fine PE, Sterne JA, Pönnighaus JM, Rees RJ. Lancet; 1994 Nov 05; 344(8932):1245-9. PubMed ID: 7967984 [Abstract] [Full Text] [Related]
28. Effect of BCG on the risk of leprosy in an endemic area: a case control study. Muliyil J, Nelson KE, Diamond EL. Int J Lepr Other Mycobact Dis; 1991 Jun 05; 59(2):229-36. PubMed ID: 2071979 [Abstract] [Full Text] [Related]
29. Tuberculosis prevention: where do we go from here? Warndorff DK. Afr Health; 1996 Nov 05; 19(1):21-2. PubMed ID: 12291917 [Abstract] [Full Text] [Related]
30. The effect of Bacille Calmette-Guérin vaccine on tuberculin reactivity in indigenous children from communities with high prevalence of tuberculosis. Araujo Z, de Waard JH, de Larrea CF, Borges R, Convit J. Vaccine; 2008 Oct 16; 26(44):5575-81. PubMed ID: 18723065 [Abstract] [Full Text] [Related]
31. Anti-leprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: lepromin skin test results. Gormus BJ, Baskin GB, Xu K, Ratterree MS, Mack PA, Bohm RP, Meyers WM, Walsh GP. Lepr Rev; 2002 Sep 16; 73(3):254-61. PubMed ID: 12449891 [Abstract] [Full Text] [Related]
32. Borderline tuberculoid leprosy following BCG vaccination. A case report. Stoner GL, Belehu A, Nsibambi J, Warndorff J. Int J Lepr Other Mycobact Dis; 1981 Mar 16; 49(1):16-20. PubMed ID: 7195879 [Abstract] [Full Text] [Related]
34. What does tuberculin reactivity after bacille Calmette-Guérin vaccination tell us? Menzies D. Clin Infect Dis; 2000 Sep 16; 31 Suppl 3():S71-4. PubMed ID: 11010826 [Abstract] [Full Text] [Related]
35. Efficacy of the BCG revaccination programme in a cohort given BCG vaccination at birth in Hong Kong. Leung CC, Tam CM, Chan SL, Chan-Yeung M, Chan CK, Chang KC. Int J Tuberc Lung Dis; 2001 Aug 16; 5(8):717-23. PubMed ID: 11495262 [Abstract] [Full Text] [Related]
37. [A retrospective study on tuberculin in children under 19]. Herranz Alvarez M, Vázquez Gallardo R, Minguella García I, Chouciño Garrido N, Otero Baamonde MI, Quiles Sotillo P. An Esp Pediatr; 1996 Mar 16; 44(3):234-8. PubMed ID: 8830597 [Abstract] [Full Text] [Related]
38. The distribution and implications of BCG scars in northern Malawi. Fine PE, Ponnighaus JM, Maine N. Bull World Health Organ; 1989 Mar 16; 67(1):35-42. PubMed ID: 2706726 [Abstract] [Full Text] [Related]